Jeremy B. Hayden, General Counsel & VP of BD at CYTORI THERAPEUTICS, INC. (CYTX), bought 18,000 shares at $0.39 ($7K) on 2015-08-19, disclosed to the SEC on 2015-08-21.
Open-market purchase of $7k CYTX by General Counsel & VP of BD. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| SGHT | SELL | 2026-01-21 | $42K | — | Filing → |
| SGHT | SELL | 2026-01-06 | $87K | — | Filing → |
| SGHT | SELL | 2025-11-26 | $362K | — | Filing → |